What guidance has Zoom Video Communications issued on next quarter's … Those terrific results have justifiably driven Zoom’s stock price higher. As Zoom’s stock price has soared, so too has its stock market valuation. Zomedica Pharmaceuticals Corp. (ZOM.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ZOM.". Zomedica Pharmaceuticals Corp. (ZOM.V) has received 65.28% “outperform” votes from our community. Learn about financial terms, types of investments, trading strategies and more. Zoom Video Communications (Nasdaq: ZM) has been nothing short of a stock market sensation in 2020. If we look at the company’s 10-day average daily trading volume, we find that it stood at 20.78 Million shares traded. written by Jody Chudley Tuesday, September 29, 2020 Zoom Video Communications (Nasdaq: ZM) has been nothing short of a stock market sensation in 2020. document.getElementById("date").innerHTML = d.getFullYear(); … Newsletter FAQs | privacy policy. Export data to Excel for your own analysis. This is a high-profit-margin business that sees revenue growth actually turn into positive cash flow. There is really no reason to use Zoom if equal or better videoconferencing alternatives exist – especially if the other offerings are less expensive. Price target in 14 days: 4.986 USD. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies. All investments carry risk and results are not guaranteed. Analyzing Zomedica Pharmaceuticals Corp. (ZOM.V) (CVE:ZOM) stock? Find real-time ZM - Zoom Video Communications Inc stock quotes, company profile, news and forecasts from CNN Business. At Zoom’s current share price, the stock market values the company at $138 billion. Wall Street analysts have given Zomedica Pharmaceuticals Corp. (ZOM.V) a "N/A" rating, but there may be better short-term opportunities in the market. How has Zomedica's stock been impacted by Coronavirus (COVID-19)? Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. That is a lot of cash flow, to be sure – but relative to Zoom’s $138 billion market valuation, it really isn’t. During the day the stock fluctuated 16.09% from a day low at $2.30 to a day high of $2.67. Get short term trading ideas from the MarketBeat Idea Engine. You may vote once every thirty days. The video conferencing expert's stock was more expensive in October and the retreat could very well run even lower from here. Identify stocks that meet your criteria using seven unique stock screeners. The result? Zoom produces what is widely believed to be the best videoconferencing software on the market. Zomedica Pharmaceuticals Corp . Learn more. View which stocks have been most impacted by COVID-19. Zoom’s lack of a protective moat will eventually be the killer for the stock. Last quarter, Zoom generated cash flow of $373 million. ZOM is now worth nearly $2 billion so it … Even better, Zoom is not some profitless growth story. (Add your “underperform” vote.). Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Even more, the company approximately doubled … According to present data Zoom Video Communications Inc - Class A's ZM shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). These companies have seen the waves of people and companies flocking to Zoom, and they want a piece of the action. View all of ZOM's competitors. Cancel. Close price at the end of the last trading day (Wednesday, 10th Feb 2021) of the ZOM stock was $2.55. By submitting your email address, you will receive a free subscription to Wealthy Retirement, and offers from us and our affiliates that we think might interest you. The average equity rating for ZOM stock is currently 2.00, trading closer to a bullish pattern in the stock market. Since then, ZOM shares have increased by 1,199.3% … Thank you for subscribing to Wealthy Retirement. © American Consumer News, LLC dba MarketBeat® 2010-2021. Zomedica's stock was trading at $0.2078 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Want to see which stocks are moving? Your email is safe with us. HC Wainwright is very positive to ZOM and gave it a "Buy" rating on November 16, 2020. I don’t dislike Zoom’s business. Sign-up to receive the latest news and ratings for ZOM and its competitors with MarketBeat's FREE daily newsletter. S&P 500 0.00%. close $2.55 : 52-week low $0.06 : Day low $2.50 : Volume 203,301,895 : Day high $2.90 : Avg. The P/E ratio of Zomedica Pharmaceuticals Corp. (ZOM.V) is -2.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Zomedica Pharmaceuticals Corp. (ZOM.V) does not have a long track record of dividend growth. ), Zomedica Pharmaceuticals Corp. (ZOM.V) has received 25 “underperform” votes. You can opt out at any time. The official website for Zomedica Pharmaceuticals Corp. (ZOM.V) is www.zomedica.com. Click here now. Zoom Stock Surged 425% in 2020: Is It a Buy for 2021? DOW 0.00%. On an annual basis, that equates to almost $1.5 billion. Vote “Underperform” if you believe ZOM will underperform the S&P 500 over the long term. Zoom’s 2020 revenue growth has been incredible. There is not enough analysis data for Zomedica Pharmaceuticals Corp. (ZOM.V). According to Zomedica (ZOM) the market for the “diagnostics segment of the global companion animal market” should reach $2.8 billion by 2024”. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Zoom's revenue soared 169% year over year to $328.2 million, crushing an average analyst forecast for revenue of $202.7 million. View our full suite of financial calendars and market data tables, all for free. How will Zoom fare in a price war with Google or Microsoft? Zoom has been the videoconferencing service of choice. That is where I get very concerned. Investors can use this forecasting interface to forecast Zomedica Pharmaceuticals historical stock prices and determine the direction of Zomedica Pharmaceuticals Corp's future trends based on various well-known forecasting models. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. The higher the valuation, the bigger a stock’s protective moat needs to be. These big competitors have the huge advantage of being able to bundle their videoconferencing software with their other offerings. Since then, ZM stock has increased by 292.4% and is now trading at $432.77. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Your free report will be delivered to your inbox. View ZOM's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat. The ZOM stock price is -22.92% off its 52-week high price of $0.59 and 86.88% above the 52-week low of $0.063. Based on aggregate information from My MarketBeat watchlists, some companies that other Zomedica Pharmaceuticals Corp. (ZOM.V) investors own include Heat Biologics (HTBX), Biocept (BIOC), Remark (MARK), Onconova Therapeutics (ONTX), Vislink Technologies (VISL), Genius Brands International (GNUS), Ritter Pharmaceuticals (RTTR), T2 Biosystems (TTOO), Guardion Health Sciences (GHSI) and MicroVision (MVIS). Zomedica Pharmaceuticals Corp. (ZOM.V) has received 47 “outperform” votes. Zoom Video Communications' stock was trading at $110.30 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. 1 analyst(s) have assigned their ratings of the stock’s forecast evaluation on a scale of 1.00-5.00 to indicate a strong buy to a strong sell recommendation. And Zoom’s moat simply doesn’t justify its current valuation. In the first quarter, it posted $328 million (up 169% year over year), and in the second quarter, it earned $663 million (up 355% year over year). View our privacy policy and newsletter FAQs. Alphabet‘s (Nasdaq: GOOGL) Google, Facebook (Nasdaq: FB), Microsoft (Nasdaq: MSFT), Cisco Systems (Nasdaq: CSCO) and a host of other companies have all cranked up their focus on videoconferencing. I don’t see how Zoom’s growth won’t quickly be shut down by deep-pocketed competition. Log In. What I’m telling you is that Zoom offers a great service and has a profitable, free-cash-flow-generating business that is growing rapidly. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. It entered the year at $68. You’ll soon read about proven strategies that will enable you to generate income and build the future you want. The company can be reached via phone at 734-369-2555. Zomedica Pharmaceuticals Corp. (ZOM.V) does not currently pay a dividend. Zomedica Pharmaceuticals Corp 2.66 0.11 (4.31%) Watch. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. var d = new Date(); Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Find real-time ZOM - Zomedica Corp stock quotes, company profile, news and forecasts from CNN Business. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Zomedica Corp Stock Price Forecast, "ZOM" Predictons for2021 The company is also developing ZM-012, a tablet formulation of metronidazole targeting the treatment of acute diarrhea in dogs; ZM-006, a transdermal gel formulation of methimazole targeting hyperthyroidism in cats; and ZM-011, a transdermal gel formulation of fluoxetine for the treatment of feline behavioral disorders, such as inappropriate urination. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Current price $2.66 : 52-week high $2.91 : Prev. One share of ZOM stock can currently be purchased for approximately C$0.29. The 3-month trading volume is 52.32 Million shares. All of Zoom’s valuation metrics look incredibly expensive. Thank you for signing up for Wealthy Retirement. So why do I think investors should sell any shares of Zoom that they own today? Much of … Vote “Outperform” if you believe ZOM will outperform the S&P 500 over the long term. You can unsubscribe at any time. I think they are going to get it. The 3-month trading volume is 84.47 Million shares. The stock ended 2020 priced at $0.23 but has since steadily climbed to its closing price on Friday of $2.57 which represents gains of over 1,000% in 2021 alone. To judge whether $138 billion is expensive, compare the cash flow and earnings that the business generates. 2: There is nothing stopping much more powerful competitors from offering a superior or equal product and eating Zoom’s lunch. List of ZOM stock predictions for today. © Wealthy Retirement ZOM: Get the latest Zomedica stock price and detailed information including ZOM news, historical charts and realtime prices. The one-year ZOM stock forecast points to a potential downside of -59.17. In the past three months, Zomedica Pharmaceuticals Corp. (ZOM.V) insiders have not sold or bought any company stock. Receive a free world-class investing education from MarketBeat. Get daily stock ideas top-performing Wall Street analysts. MarketBeat just released five new trading ideas, but Zomedica Pharmaceuticals Corp. (ZOM.V) wasn't one of them. In order for the stock price to hit the forecast high, the stock would need to surge -69.39% from its current level, while the stock would need to crash -69.39% from its current level to reach the projected low. It has a collaboration agreement with Celsee Diagnostics, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and with Seraph Biosciences, Inc. for development and commercialization of novel pathogen detection system. Get the hottest stocks to trade every day before the market opens 100% free. Zomedica Pharmaceuticals Corp. (ZOM.V) has a P/B Ratio of 5.82. Do Not Sell My Information. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. | 877.808.9795 | 443.353.4621 | 105 W Monument Street | Baltimore, MD 21201. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. In 2020, businesses across the globe have scrambled to conduct meetings from home. 1: Zoom’s current valuation is crazy expensive relative to the cash flow that the business generates. Find the latest Zomedica Corp. (ZOM) stock quote, history, news and other vital information to help you with your stock trading and investing. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. All rights reserved. Zoom Technologies, Inc. () Stock Market info Recommendations: Buy or sell Zoom Technologies stock? I most definitely wish I had owned shares of Zoom on January 1 and held through today…, But if I did, I can tell you the first thing I would do…. Buy. That is what we call a “seven-bagger” in this business. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 It entered the year at $68. ZOM -- USA Stock : USD 0.17 0.01 6.25% : Zomedica Pharmaceuticals Stock Forecast is based on your current time horizon. Guru’s Opinion on Zomedica Corp. [ZOM]: Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ZOM shares is $1.20 per share. The big boys are coming after Zoom with videoconferencing offerings of their own. Now it trades for more than $480. Some companies that are related to Zomedica Pharmaceuticals Corp. (ZOM.V) include ESSA Pharma Inc. (EPI.V) (EPI), Venture Life Group plc (VLG.L) (VLG), WeedMD Inc. (WMD.V) (WMD), Acerus Pharmaceuticals Co. (ASP.TO) (ASP), Delta 9 Cannabis (NINE), Diurnal Group (DNL), The Flowr (FLWR), BioSyent Inc. (RX.V) (RX), Science in Sport (SIS), Shield Therapeutics plc (STX.L) (STX), InMed Pharmaceuticals Inc. (IN.TO) (IN), Medexus Pharmaceuticals (MDP), Viridium Pacific Group (VIR), Indiva Limited (NDVA.V) (NDVA) and Cipher Pharmaceuticals Inc. (CPH.TO) (CPH). Rooms Shows Rankings Earnings Calendar Shop. Zomedica Pharmaceuticals Corp. (ZOM.V)'s management team includes the following people: Start Your Risk-Free Trial Subscription Here, Luxury car brand Jaguar to go all-electric by 2025, The Latest: Variants-wary Germany turns back 5,000 at border, Tokyo surges to 30-year high as world shares rally, World stocks rally, bringing Japanese market to 30-year high, The Latest: Britain orders quarantine for many travelers, Biden faces questions about commitment to minimum wage hike, Got no milk: Nestle creates vegan KitKat bar, Sketchers U.S.A. Stock is a Pullback Opportunity Here, 3 Stocks Under $20 Set for Big 2021 Gains, 3 Dating App Stocks for Investors to Love, 3 Consumer Discretionary Stocks Ready to Run, 3 Oil & Gas Stocks Worth Watching in 2021, U.S. Steel Stock is an Economic Recovery Buy Here, American Axle Manufacturing Stock is an Automotive Recovery and Electrification Play, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, Why Zomedica Stock Soared Today and Then Plunged in After-Hours Trading, Tonix, Biolase Join Penny Stocks Surge After Reddit Touts, What Investors Should Know Before Buying Surging Penny Stocks, 3 Top Penny Stocks For Your December 2020 Watch List, 41 Stocks Moving in Wednesday's Pre-Market Session, Zomedica to Develop Gastrointestinal Testing Panel for TRUFORMA™, Zomedica Announces Letter From Robert Cohen, Interim CEO, Made Available to Shareholders in Connection With Annual and Special Virtual-Only Meeting, Acerus Pharmaceuticals Co. (ASP.TO) (ASP), Cipher Pharmaceuticals Inc. (CPH.TO) (CPH), Receive Analysts' Upgrades and Downgrades Daily. ZOM Stock Price Chart Interactive Chart > ZOM Price/Volume Stats. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -28.5%. Sign Up. Learn everything you need to know about successful options trading with this three-part video course. Why Zoom’s Spectacular Run May Come to an End, 50 Retirement Quotes: Inspirational and Funny Retirement Sayings. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. The price target was set to $0.50 → $0.30. This is 9.91% more than the trading day before Tuesday, 9th Feb 2021. ZOM 2.66 0.11 (4.31%) Post-Market … Laying the Foundations for a Stronger Homebuilding Industry. Toggle Search. These expensive valuation multiples tell us that the market is pricing years of incredible growth into Zoom’s future. Now it trades for more than $480. Fundamental company data provided by Zacks Investment Research. Welcome! See what's happening in the market right now with MarketBeat's real-time news feed. volume 288,909,563 : 50-day MA $0.75 : Dividend yield N/A : 200-day MA $0.30 : Market Cap 1.50B : Zomedica Pharmaceuticals Corp. Common Shares (ZOM) Company Bio. Zomedica Pharmaceuticals Corp. (ZOM.V) has a market capitalization of C$36.73 million. Zomedica Stock Forecast, ZOM stock price prediction. Reason No. The stock is rated as a Hold by none analyst(s), 1 recommend it as a Buy and no body called the ZOM stock Outperform. Please log in to your account or sign up in order to add this asset to your watchlist. That means Zoom shares are a risky proposition today. (Add your “outperform” vote. The only response that Zoom will have is to lower prices – and that will have an immediate impact on the financial performance of the company, which will in turn hit Zoom’s stock price. Real-time trade and investing ideas on Zomedica Pharmaceuticals Corp ZOM from the largest community of traders and investors. Quite the contrary, actually. Trending now. View which stocks are hot on social media with MarketBeat's trending stocks report. Looking for new stock ideas? Zomedica Corp. (ZOM) projections and forecasts. Shares of ZOM and other Canadian stocks can be purchased through an online brokerage account. To see all exchange delays and terms of use please see disclaimer. Top Buy Candidates; Possible Runners; Double Bottoms; Pivot Bottoms; By Score & Duration; Undervalued List; Golden Star Short ; Golden Star Long; Bollinger BreakOut; Moving Averages Short term; 7 days mv; 35 days mv; Medium term; 100 days mv; 200 days mv; Short/long (Golden cross) 7 / 35 days; 35 / 100 days; Sell. Reason No. If we look at the company’s 10-day average daily trading volume, we find that it stood at 316.55 Million shares traded. NASDAQ 0.00%. Trading Ideas. It sports a price-to-earnings ratio of 538 and a price-to-cash-flow ratio of 92. In the meantime, none analyst(s) believe the stock as Underperform and none think it is a Sell. MarketBeat's community ratings are surveys of what our community members think about Zomedica Pharmaceuticals Corp. (ZOM.V) and other stocks. Get access to all of the retirement secrets and income strategies from our experts! With the pandemic forcing everyone to work from home, Zoom was in exactly the right place at exactly the right time. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Zoom Video Communications Inc - Class A share forecasts, stock quote and buy / sell signals below. Zomedica Pharmaceuticals Corp. (ZOM.V) employs 27 workers across the globe. In the second quarter, Zoom had free cash flow of $373 million. The ZOM stock price is -353.64% off its 52-week high price of $0.499 and 4.55% above the 52-week low of $0.105. If you owned $10,000 worth of Zoom shares on January 1, those shares are now worth more than $70,000. Learn more. The company was founded in 2015 and is headquartered in Ann Arbor, Michigan.
Cheaper Alternative To Kevin Murphy, Babylock Triumph Uk, Alien Dichotomous Key Answers, Eureka Strawberry Cough 1000mg, Is Run The Gauntlet Cursed,